urinary stone disease(Shireyunjie-category)
Conditions
Interventions
High dose group:high dose Desmodium styracifolium total flavone capsule
midle dose group:midle dose Desmodium styracifolium total flavone capsule
Low dose group:low dose Desmodium styracifolium total flavone capsule
Sponsors
People's Hospital Affiliated to Fujian University of TMC
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Stone in the renal pelvis or ureter stone; (2) Male and female aged 18 to 65 years old; (3) Stone diameter: 0.4cm< diameter<=l.0cm; (4) Renal function is good, especially the ipsilateral renal function is good, if the patients have kidney ponding, the degree of hydronephrosis in moderate following; (5) General condition is good, life can take care of themselves; (6) Signed informed consent form.
Exclusion criteria
Exclusion criteria: (1) Kidney, ureter junction, or distal ureteral calculi with malformations, stenosis, obstruction and operation scar adhesion; (2) severe hydronephrosis (grade III); (3) sustained severe hematuria, or even shock; (4) acute obstructive oliguria, anuria; (5) during pregnancy, breastfeeding women; (6) with cardiovascular, hepatic, renal, hematopoietic system of severe primary disease, or to affect the survival of the serious diseases (such as cancer or AIDS), or mental or legally disabled patients; (7) the liver function ALT and/or AST values in normal values outside; (8) a month over the use of surgical intervention in the treatment of urolithiasis; (9) on the basis of judgment, can reduce the likelihood or make into the group into the group of complex of other lesions, such as work environment often change is easy to cause the loss of follow up; (10) within the past three months, participated in drug clinical trials; (11) known to the drugs or their composition allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stone does exclude; | — |
Countries
China
Contacts
Public ContactZhou Hao
Outcome results
None listed